Clinical Read2026-06-08

Korlym - (CATALYST)

Name: Korlym - (CATALYST)
Start: 2026-06-08

Corcept Therapeutics IncorporatedCORT

Indication: Hypercortisolism (Cushing's Syndrome) and Difficult-to-Control Diabetes
Stage: phase1
Event: Phase 1